Decreased frequency of sEPSCs in <i>Dyt1</i> heterozygous KO mice. by Fumiaki Yokoi (170876)

CHNRI's conceptual framework showing key steps required to get from investments in health research options to decrease in burden of death, disease, or disability. by Igor Rudan (150101)

<i>neurod1</i>^<i>ΔUCE</i> homozygous mutants display a decrease in the expression of several EE hormones. by Anne Sophie Reuter (12239993)

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…A representative HPD <b>1466</b>, with a 50% effective concentration against HBV replication of 0.25 µM, decreased capsid and core protein accumulation by 50–90% in HepDES19 and HepG2.2.15 cells. …”

Raw data. by Adrian Bartoszek (20826922)

“…Seizures were induced by adding PTZ to achieve a final concentration of 20 mM. In the PTZ-induced seizure model, the application of CAF in doses over 50 mg/L resulted in a decrease in the average movement. …”

Predictive values of IC₅₀ in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC₅₀ in mM (FFAs) and decreasing blood glucose level. by Elena V. Fedorova (603922)

Antifungal effect of WSWE on <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

Determination of minimum fungicidal concentration of WSWE against <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

WSWE targets both cell wall and cell membrane of <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

Micromorphological impact of WSWE treatment on <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Subjects:

Proposed model of mode of action of WSWE as anti-fungal agent. by Acharya Balkrishna (5640038)

Subjects:

WSWE treatment reduced total ergosterol amount in <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Subjects:

Time kill kinetics of WSWE against <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

Differential expression analysis of nuclear transcripts after siAPOBEC3A depletion reveals induction of TP53 targets and decreases in cell cycle and cell growth regulator transcrip... by Mason A. McCool (11889842)

Top 50 genes whose expression is most decreased in PN11 <i>Klf5</i>CN compared with the WT corneas. by Doreswamy Kenchegowda (135193)

Top 50 genes whose expression is most decreased in PN56 <i>Klf5</i>CN compared with the WT corneas. by Doreswamy Kenchegowda (135193)

Susceptibility of half knockout strains to CYP51 inhibitors (EC50, μM): compounds with decreased activity on HKO + CYP strains. by Laura-Isobel McCall (222498)

KDM6A mRNA expression is decreased in PTFE mice. by Simon Lebek (9756148)

DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

“…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”

DataSheet_1_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

“…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”